11 min listen
Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guidelin…
FromASCO Guidelines
Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guidelin…
FromASCO Guidelines
ratings:
Length:
9 minutes
Released:
Dec 10, 2021
Format:
Podcast episode
Description
An interview with Dr. Sharon Giordano, co-chair on “Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update.” Dr. Giordano discusses the results and impact of the monarchE trial, the updated recommendations on the use of abemaciclib, and impact for clinicians and patients. For more information, visit www.asco.org/breast-cancer-guidelines.
Released:
Dec 10, 2021
Format:
Podcast episode
Titles in the series (100)
Outpatient Management of Fever and Neutropenia Guideline: An interview with Dr. Christopher Flowers of Emory University School of Medicine on the ASCO/IDSA clinical practice guideline which provides updated recommendations on outpatient management of fever and neutropenia in patients with cancer.... by ASCO Guidelines